RxDoctor Payments Data

Kathryn Ruddy, MD

Medical Oncology · Rochester, MNNPI 1518948082

Payments from drug & device makers

$2,283in general payments, 2019–2025

Across 2 payments — averaging $1141.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Tersera Therapeutics LLC$2K
  • Gilead$12

What the payments were for

  • Consulting fees$2,27199%
  • Education$121%

General payments by program year

21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Tersera Therapeutics LLC1$2,271
Gilead1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,283 in reported general payments places this provider in the 30th percentile of 133 medical oncology providers in Minnesota.

See all medical oncology providers in Minnesota

Medicare billing

Part B allowed, 2024
$851,388
Medicare patients
193
Services billed
30,303

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Letrozole30$833
Tramadol Hcl13$37

Paid to pharmacies, not to this prescriber.

Other medical oncology in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →